DNA aptamers targeting glycoprotein D enable specific detection of pseudorabies virus (PRV)
Zhihao Wang , Yan Qiao , Jiafu Zhao , Xiaotian Chang , Heshui Zhu , Chao Zhang
Animal Diseases ›› 2025, Vol. 5 ›› Issue (1) : 10
DNA aptamers targeting glycoprotein D enable specific detection of pseudorabies virus (PRV)
Pseudorabies virus (PRV, SuidAlphaherpesvirus 1) causes substantial economic losses in swine production. Here, we report the development of DNA aptamers targeting the PRV glycoprotein D (gD) through an optimized SELEX protocol. After 15 selection cycles, Apt-gD-2 demonstrated nanomolar affinity (Kd = 6.107 ± 0.476 nM) and high specificity for gD, as validated by an enzyme-linked aptamer-sorbent assay (ELASA) and fluorescence microscopy. Molecular docking revealed hydrogen bonding as the key interaction mechanism. The developed ic-ELASA achieved 83.3% concordance with qPCR in clinical samples, supporting its utility for on-farm PRV surveillance. These findings highlight the potential of aptamer-based diagnostic methods for rapid, sensitive, and onsite detection of PRV, offering a promising tool for disease control in the swine industry.
Aptamer / Pseudorabies virus / Glycoprotein D / ELASA / Viral diagnosis
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Gao, Y., T. Xia, J. Bai, L. Zhang, H. Zheng, and P. Jiang. 2022. Preparation of monoclonal antibodies against the viral p54 protein and a blocking ELISA for detection of the antibody against African swine fever virus. Viruses 14(11). https://doi.org/10.3390/v14112335. |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
Morais, L. M., T. S. Chaves, M. A. Medeiros, K. A. B. Pereira, P. B. Jurgilas, S. M. Barbosa de Lima, S. Missailidis, and A. M. Bispo de Filippis. 2022. Selection and characterization of single-stranded DNA aptamers of diagnostic potential against the whole Zika virus. Viruses 14(9). https://doi.org/10.3390/v14091867. |
| [17] |
|
| [18] |
|
| [19] |
Nimjee, S.M., R.R. White, R.C. Becker, and B.A. Sullenger. 2017. Aptamers as therapeutics. Annual Review of Pharmacology and Toxicology 57:61–79. https://doi.org/10.1146/annurev-pharmtox-010716-104558. |
| [20] |
|
| [21] |
Ommen, P., L. Hansen, B.K. Hansen, H. Vu-Quang, J. Kjems, and R.L. Meyer. 2022. Aptamer-targeted drug delivery for Staphylococcus aureus biofilm. Frontiers in Cellular and Infection Microbiology 12:814340. https://doi.org/10.3389/fcimb.2022.814340. |
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
Zheng, H. H., P. F. Fu, H. Y. Chen, and Z. Y. Wang. 2022. Pseudorabies virus: From pathogenesis to prevention strategies. Viruses 14(8). https://doi.org/10.3390/v14081638. |
| [37] |
Zhou, Q., L. Zhang, H. Liu, G. Ye, L. Huang, and C. Weng. 2022. Isolation and characterization of two pseudorabies virus and evaluation of their effects on host natural immune responses and pathogenicity. Viruses 14(4). https://doi.org/10.3390/v14040712. |
| [38] |
|
| [39] |
Zou, X., J. Wu, J. Gu, L. Shen, and L. Mao. 2019. Application of aptamers in virus detection and antiviral therapy. Frontiers in Microbiology 10:1462. https://doi.org/10.3389/fmicb.2019.01462. |
The Author(s)
/
| 〈 |
|
〉 |